Abbott Q1 ’22 Earnings Update; New YouTube Video Featuring Libre 2 App

Abbott hosted its Q1 ’22 earnings call (press release; view infographic) and provided updates on its Libre business. Unsurprisingly, much of the call focused on Abbott’s COVID-19 testing and business recovery. Of note, Abbott reported that the WW Libre user base has reached ~4M users. Separately, Abbott recently posted a new Libre 2 smartphone compatibility video on the company’s FreeStyle US YouTube channel (view video). Below are diabetes-related highlights from the call as well as insights regarding Abbott’s newly posted video.

About The Author

Matthew Maryniak

President of Fenix Group International

Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.

If you receive our email blasts, you already have an account.

Purchase Blast$599.00

You can read the article’s full content online after purchase.